Lapatinib’in sıçan over ve uterus dokuları üzerine olan etkilerinin ışık ve elektron mikroskobik düzeyde araştırılması

by Hande Tokgönül, Yurdun Kuyucu, Ufuk Mete
Published 2020-09-01

The Efficacy of Pyrotinib as a Third- or Higher-Line Treatment in HER2-Positive Metastatic Breast Cancer Patients Exposed to Lapatinib Compared to Lapatinib-Naive Patients: A Real-...

by D. J Ouyang, D. J Ouyang, Q. T Chen, M. Anwar, N. Xie, Q. C. Ouyang, P. Z. Fan, L. Y. Qian, G. N. Chen, E. X. Zhou, L. Guo, X. W. Gu, B. N. Ding, X. H. Yang, L. P. Liu, C. Deng, Z. Xiao, J. Li, Y. Q. Wang, S. Zeng, Shouman Wang, Wenjun Yi
Published 2021-08-01

Lapatinib in combination with capecitabine versus continued use of trastuzumab in breast cancer patients with trastuzumab-resistance: a retrospective study of a Chinese population

by Fan Yang, Xiang Huang, Chunxiao Sun, Jianbin Li, Biyun Wang, Min Yan, Feng Jin, Haibo Wang, Jin Zhang, Peifen Fu, Tianyu Zeng, Jian Wang, Wei Li, Yongfei Li, Mengzhu Yang, Jun Li, Hao Wu, Ziyi Fu, Yongmei Yin, Zefei Jiang
Published 2020-03-01

Lapatinib and capecitabine as third-line therapy in young woman with advanced breast cancer

by Michela Donadio
Published 2018-06-01

Lapatinib Induced Suicidal Death of Human Erythrocytes

by Jens Zierle, Rosi Bissinger, Jasmin Egler, Florian Lang
Published 2015-12-01

Combination of Selected MET and EGFR Inhibitors Decreases Melanoma Cells’ Invasive Abilities

by Aleksandra Simiczyjew, Katarzyna Pietraszek-Gremplewicz, Ewelina Dratkiewicz, Marta Podgórska, Rafał Matkowski, Rafał Matkowski, Marcin Ziętek, Marcin Ziętek, Dorota Nowak
Published 2019-10-01

Systemic control of cerebral metastases in a patient with HER2-positive metastatic breast cancer. Clinical case

by S. F. Menshikova, M. A. Frolova, M. B. Stenina
Published 2019-06-01

Role of yes-associated protein in resistance of HER2+ breast cancer to lapatinib

by CHEN Peng, XU Ting, GUO Dan, HUANG Jiayi
Published 2020-04-01

Adipocyte-conditioned medium induces resistance of breast cancer cells to lapatinib

by A. Geneste, M. N. Duong, L. Molina, L. Conilh, S. Beaumel, A. Cleret, K. Chettab, M. Lachat, L. P. Jordheim, E. L. Matera, C. Dumontet
Published 2020-08-01

Cross-Database Analysis Reveals Sensitive Biomarkers for Combined Therapy for ERBB2+ Gastric Cancer

by Zhen Xiang, Xia Huang, Jiexuan Wang, Jun Zhang, Jun Ji, Ranlin Yan, Zhenggang Zhu, Wei Cai, Yingyan Yu
Published 2018-08-01

Association between efficacy and skin rash following treatment with the lapatinib in metastatic breast cancer

by Suleyman Temiz, Serap Kaya, Gokhan Erbag, Gorkem Aksu, Kazım Uygun
Published 2016-04-01

Rapid symptomatic relief of HER2-positive gastric cancer leptomeningeal carcinomatosis with lapatinib, trastuzumab and capecitabine: a case report

by Xiao-Dong Jiao, Chunming Ding, Yuan-Sheng Zang, Guanzhen Yu
Published 2018-02-01

Synergistic Antitumor Effects on Drug-Resistant Breast Cancer of Paclitaxel/Lapatinib Composite Nanocrystals

by Jun Wang, Feng-Mei Lv, Dong-Li Wang, Jian-Liang Du, Hai-Yan Guo, Hai-Ni Chen, Shou-Jin Zhao, Zhe-Peng Liu, Yu Liu
Published 2020-01-01

Trastuzumab emtansine in locally advanced or metastatic HER2 positive breast cancer; GENESIS-SEFH drug evaluation report

by Patricia Miranda Romero, Roberto Marín Gil
Published 2015-02-01

Lapatinib induces autophagic cell death and differentiation in acute myeloblastic leukemia

by Chen YJ, Fang LW, Su WC, Hsu WY, Yang KC, Huang HL
Published 2016-07-01

Budget impact analysis of the use of lapatinib in the treatment of breast cancer in Italy

by Francesco Bamfi, Federica Basso, Massimo Aglietta, Carmelo Bengala, Vito Lorusso, Paolo Pronzato, Maria Caterina Cavallo, Orietta Zaniolo, Sergio Iannazzo
Published 2009-03-01

Tissu adipeux et résistance tumorale aux thérapies ciblées

by Geneste, Aline
Published 2018

Etude de l’effet sur la P‐glycoprotéine (ABCB1) de deux médicaments dirigés contre le récepteur de facteur de croissance épithélial (EGFR), le cétuximab et le lapatinib et conséque...

by Chu, Céline
Published 2013

Targeting HER 1 and 2 in breast cancer with lapatinib

by Gerald M. Higa
Published 2011-12-01

Long-term survival in a young woman with recurrent HER2-positive breast cancer.

by Gianluca Cotroneo
Published 2018-06-01